Results 171 to 180 of about 419,079 (384)
Organoid Models to Study Human Infectious Diseases
Cell Proliferation, EarlyView.Our manuscript reviews the role of organoids as models for studying human infectious diseases, highlighting their irreplaceable contributions to drug testing and vaccine development for significant infectious diseases including HIV, ZIKV, SARS‐CoV‐2 and MPXV.
Sijing Zhu +4 more
wiley +1 more source
Chip Shots: Association Between the State Children's Health Insurance Programs and Immunization Coverage and Delivery [PDF]
By age two a child who is up to date for immunizations will have received up to 19 shots delivered over eight visits at a market cost of $525 dollars for the vaccines alone, a far more expensive and demanding regimen that the 8 shots received in 1987. In
Andrew Racine, Ted Joyce
core
Cell Proliferation, EarlyView.CRISPR‐Cas systems offer transformative genome editing capabilities for precise manipulation of cellular genes. This enables two main therapeutic avenues: ex vivo modification of patient cells for re‐transplantation or direct in vivo gene targeting via advanced delivery methods.
Bahareh Farasati Far +4 more
wiley +1 more source
Immunogenicity of low-dose plasma-derived hepatitis B vaccine [PDF]
, 1997 Mark Kane, Julie B. Milstien
openalex +1 more source
The potential of 1018 ISS adjuvant in hepatitis B vaccines
Human Vaccines & Immunotherapeutics, 2013 Nelson F. Eng +3 more
semanticscholar +1 more source
Health Information &Libraries Journal, EarlyView.Abstract Background The inclusion of marginalized populations in health information research is crucial for ensuring equitable health outcomes and addressing systemic disparities. However, underrepresentation of these groups remains a significant issue, particularly in health misinformation correction research.
Romy RW, Junhan Chen, Yuan Wang
wiley +1 more source
State of Alaska epidemiology bulletin: Hepatitis B and hepatitis B vaccine
, 1983 openalex +1 more source
Twelve-year follow-up of a prospective randomized trial of hepatitis b recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children [PDF]
, 1999 Man‐Fung Yuen +4 more
openalex +1 more source
Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK [PDF]
, 2013 Alderton, W K +3 more
core +1 more source